Tag: oral-version
-
Cytokinetics, Amgen drug shows promise in heart failure study
By Bill Berkrot ORLANDO (Reuters) – An experimental heart failure drug being developed by Cytokinetics Inc and Amgen Inc demonstrated several beneficial cardiac function effects in a midstage clinical trial, according to data presented on Sunday. The trial of 448 patients with chronic heart failure already receiving optimal care tested a twice-a-day oral version of…